| Source:
This literature review details the key findings on the feasibility and acceptability of home delivery of depo-subQ provera 104™ in the Uniject™ injection system (depo-subQ in Uniject). The review focused on self-injection and looked specifically at subcutaneous depot medroxyprogesterone acetate (DMPA) compared to the intramuscular formulation; considerations for home administration of injectable contraception, particularly in low-resource settings; and identified research needs for home administration, including self-injection, of depo-subQ in Uniject. A six-page briefing summary of this review is also available.
- Regions/Countries:
- Global |
- Global
WHO Upholds Guidance: Women With or at Risk of HIV Can Safely Use Hormonal Methods
WHO released a statement on February 16, 2012, upholding guidance indicating that women with HIV or at high risk of HIV can safely use hormonal contraceptives, including injectables, to prevent pregnancy. However, WHO is instructing health care providers to strongly advise such women who decide to use progestin-only injectables to also always use male or female condoms for protection against HIV. Read more about WHO's statement.
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.